Mass Screening

"Mass Screening" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Organized periodic procedures performed on large groups of people for the purpose of detecting disease.

Descriptor ID	D008403
MeSH Number(s)	E01.370.500 E05.318.308.980.438.580 N02.421.726.233.443 N05.715.360.300.800.438.500 N06.850.520.308.980.438.580 N06.850.780.500
Concept/Terms	Mass Screening Mass Screening Mass Screenings Screening, Mass Screenings, Mass Screening Screening Screenings

Below are MeSH descriptors whose meaning is more general than "Mass Screening".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Mass Screening [E01.370.500]
Investigative Techniques [E05]
Epidemiologic Methods [E05.318]
Data Collection [E05.318.308]
Surveys and Questionnaires [E05.318.308.980]
Health Surveys [E05.318.308.980.438]
Mass Screening [E05.318.308.980.438.580]
Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Diagnostic Services [N02.421.726.233]
Mass Screening [N02.421.726.233.443]
Health Care Quality, Access, and Evaluation [N05]
Quality of Health Care [N05.715]
Health Care Evaluation Mechanisms [N05.715.360]
Data Collection [N05.715.360.300]
Surveys and Questionnaires [N05.715.360.300.800]
Health Surveys [N05.715.360.300.800.438]
Mass Screening [N05.715.360.300.800.438.500]
Environment and Public Health [N06]
Public Health [N06.850]
Epidemiologic Methods [N06.850.520]
Data Collection [N06.850.520.308]
Surveys and Questionnaires [N06.850.520.308.980]
Health Surveys [N06.850.520.308.980.438]
Mass Screening [N06.850.520.308.980.438.580]
Public Health Practice [N06.850.780]
Mass Screening [N06.850.780.500]

Below are MeSH descriptors whose meaning is related to "Mass Screening".

Below are MeSH descriptors whose meaning is more specific than "Mass Screening".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mass Screening" by people in this website by year, and whether "Mass Screening" was a major or minor topic of these publications.

Bar chart showing 187 publications over 24 distinct years, with a maximum of 20 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	1	3
1999	2	1	3
2000	1	1	2
2002	2	3	5
2003	7	7	14
2004	6	3	9
2005	8	1	9
2006	6	1	7
2007	6	6	12
2008	14	6	20
2009	9	10	19
2010	8	4	12
2011	10	2	12
2012	6	4	10
2013	5	2	7
2014	6	1	7
2015	6	2	8
2016	1	2	3
2017	3	2	5
2018	4	2	6
2019	1	1	2
2020	1	3	4
2021	0	3	3
2022	0	5	5

Below are the most recent publications written about "Mass Screening" by people in Profiles.

Shusted CS, Evans NR, Kane GC, Juon HS, Barta JA. Analysis of Lung Cancer Screening by Race After USPSTF Expansion of Screening Eligibility in 2021. JAMA Netw Open. 2022 Jun 01; 5(6):e2217578.

View in: PubMed
DiCarlo M, Myers P, Daskalakis C, Shimada A, Hegarty S, Zeigler-Johnson C, Juon HS, Barta J, Myers RE. Outreach to primary care patients in lung cancer screening: A randomized controlled trial. Prev Med. 2022 Jun; 159:107069.

View in: PubMed
Keck JW, Bush M, Razick R, Mohammadie S, Musalia J, Hamm J. Performance of formal smell testing and symptom screening for identifying SARS-CoV-2 infection. PLoS One. 2022; 17(4):e0266912.

View in: PubMed
McIntire RK, Lewis E, Zeigler-Johnson C, Shusted C, Barta J, Juon HS, Keith SW, Klein G. Estimating Eligibility for Lung Cancer Screening by Neighborhood in Philadelphia Using Previous and Current USPSTF Guidelines. Popul Health Manag. 2022 04; 25(2):254-263.

View in: PubMed
Seedor RS, Meeker CR, Lewis B, Handorf EA, Filchner KA, Varadarajan R, Hensold J, Padmanabhan A, Negin B, Blankstein K, Chawla NR, Song WF, Epstein J, Winn J, Goldstein LJ, Dotan E. Prospective Comparison of Geriatric Assessment and Provider's Assessment of Older Adults With Metastatic Breast Cancer in the Community. Oncologist. 2022 03 04; 27(2):e133-e141.

View in: PubMed
Cooperberg MR, Lin DW, Morgan TM, Chapin BF, Chen RC, Eggener SE. Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer. J Urol. 2022 02; 207(2):262-264.

View in: PubMed
Careyva BA, Greenberg G, Kruklitis R, Shaak K, Stoeckle JJ, Stephens J. Key Factors Promoting Rapid Implementation of Virtual Screening Modalities for the COVID-19 Pandemic Response. J Am Board Fam Med. 2021 Feb; 34(Suppl):S55-S60.

View in: PubMed
Banerjee ES, Shaak K, Burgess N, Johnson M, Careyva B. Factors Associated with Clinician Adherence to USPSTF Diabetes Screening Recommendations. J Prim Care Community Health. 2021 Jan-Dec; 12:21501327211016579.

View in: PubMed
Coppock D, Chou E, Gracely E, Gross R, Heun-Lee D. Hepatitis C antibody screening and determinants of initial and duplicate screening in the baby boomer patients of six urban primary care clinics. PLoS One. 2020; 15(7):e0235778.

View in: PubMed
Giri VN, Hyatt C, Leader A. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice. J Urol. 2020 12; 204(6):1116-1118.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement